Macleods Pharma

Rediff.com » News » Macleods Pharma

News for Macleods Pharma

Business

Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

3 Indian pharma cos recall products in US market

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug......

Over 340 drugs to go off the shelves soon

Some of the popular brands that would be impacted include Phensedyl (Abbott), Tixylix (Abbott), Gluconorm PG (Lupin), Ascoril D (Glenmark), Solvin Cold (Ipca), D Cold Total (Paras Pharma). The......

Ban on combination drugs: Knee-jerk reaction won't help

The government had formed a panel under Chandrakant Kokate to study over 6,000 combinations, of which it listed 963 as irrational. The government’s decision to ban 344 fixed-dose combinations......

Drugs ban: These are the worst hit brands, companies

Govt bans brands with annual sales worth Rs 3,728 crore. Image: Companies likely to be most affected are Pfizer, Abbott and Macleods Pharma. Photograph: Reuters The government has......

Rediff News

Macleods Pharma

News for Macleods Pharma

Domestic pharma market grew by 6.8% in 2023

3 Indian pharma cos recall products in US market

Over 340 drugs to go off the shelves soon

Ban on combination drugs: Knee-jerk reaction won't help

Drugs ban: These are the worst hit brands, companies

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS